OTCMKTS:RNUGF ReNeuron Group (RNUGF) Stock Price, News & Analysis → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free RNUGF Stock Alerts $0.0029 0.00 (0.00%) (As of 06/11/2024 ET) Add Compare Share Share Today's Range$0.0029▼$0.002950-Day Range$0.00▼$0.0552-Week Range$0.00▼$0.05VolumeN/AAverage Volume9 shsMarket Capitalization$165,793.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get ReNeuron Group alerts: Email Address Ad Gold Safe ExchangeGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing demand from Central Banks and billionaires to EXPLODE! The elites are buying up gold like nothing we've seen before… Click here now to download the free Precious Metals Buying Guide. About ReNeuron Group Stock (OTCMKTS:RNUGF)ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.Read More RNUGF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RNUGF Stock News HeadlinesOctober 18, 2023 | investing.comRugvista Group AB (RUG)April 3, 2023 | proactiveinvestors.comReNeuron appoints new scientific advisory boardFebruary 17, 2023 | proactiveinvestors.comReNeuron has extended cash runway as it focuses on validating its exosome platformDecember 8, 2022 | proactiveinvestors.comReNeuron says positive iPSC data presented at conferenceDecember 8, 2022 | proactiveinvestors.comReNeuron Group says positive iPSC data presented at conferenceDecember 2, 2022 | proactiveinvestors.comReNeuron unveils jump in revenue for first-half of 2022; issues a funding updateNovember 3, 2022 | finance.yahoo.comReNeuron Group (RENE): Re-initiation - Rebranding in Exosome Targeted Drug DeliverySeptember 14, 2022 | markets.businessinsider.comReNeuron Group Names John Hawkins CFO - Quick FactsSee More Headlines Receive RNUGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ReNeuron Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/11/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:RNUGF Previous SymbolNASDAQ:RNUGF CUSIPN/A CIKN/A Webwww.reneuron.com Phone44-20-3819-8400FaxN/AEmployees26Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.08 Current Ratio1.51 Quick RatioN/A Sales & Book Value Annual Sales$640,000.00 Price / Sales0.26 Cash FlowN/A Price / Cash FlowN/A Book Value$0.11 per share Price / Book0.03Miscellaneous Outstanding Shares57,170,000Free FloatN/AMarket Cap$165,793.00 OptionableNot Optionable Beta-0.11 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Iain Gladstone Ross B.Sc. (Age 70)BSc (Hons), C.DIR, CH.D, Executive Chairman Comp: $535.43kMr. John Michael Hawkins A.C.A. (Age 58)Company Secretary, CFO & Director Comp: $240.21kDr. John David Sinden B.A. (Age 73)BA, M.A., MA, Ph.D., Co-Founder Comp: $128.25kMs. Suzanne HancockChief Operations OfficerDr. Randolph Corteling Ph.D.Chief Scientific OfficerMr. Simon DewChief Business OfficerMore ExecutivesKey CompetitorsAisinOTCMKTS:ASEKYAllkemOTCMKTS:OROCFAmadeus IT GroupOTCMKTS:AMADYAmplifonOTCMKTS:AMFPFANAOTCMKTS:ALNPYView All Competitors RNUGF Stock Analysis - Frequently Asked Questions How have RNUGF shares performed in 2024? ReNeuron Group's stock was trading at $0.0515 at the beginning of 2024. Since then, RNUGF shares have decreased by 94.4% and is now trading at $0.0029. View the best growth stocks for 2024 here. How do I buy shares of ReNeuron Group? Shares of RNUGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RNUGF) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredNVDA to close the AI “wealth window’ June 25?On Tuesday, June 25, in front of executives from nearly every major tech company in existence, key leaders at ...Paradigm Direct | Sponsored"If I Die, I’d Trust 50% of My Daughters’ Inheritance in ONE Stock.""I'd Feel Secure Putting 50% of My Kids' Inheritance in THIS Stock" One Wall Street millionaire bought AAPL...Stansberry Research | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReNeuron Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ReNeuron Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.